DOCS Doximity, Inc.
Healthcare$19.94+2.84%ClosedMarket Cap: $3.73B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$29.47
Target (Median)
$26.00
Target Range
$18.00 - $59.00
Upside from current price: 47.8%
Rating Distribution
5 Strong Buy11 Buy12 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Goldman Sachs | maintain | Neutral | Neutral |
| 2026-05-15 | Barclays | downgrade | Equal Weight | Overweight |
| 2026-05-14 | Mizuho | maintain | Neutral | Neutral |
| 2026-05-14 | BMO Capital | maintain | Market Perform | Market Perform |
| 2026-05-14 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-05-14 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-05-14 | BTIG | downgrade | Neutral | Buy |
| 2026-05-14 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-05-14 | Wells Fargo | downgrade | Equal Weight | Overweight |
| 2026-05-14 | Needham | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Wed Mar 31 | $1.62 | $697.4M | 13 |
| Fri Mar 31 | $1.59 | $714.5M | 10 |
| Sat Mar 31 | $1.86 | $769.1M | 2 |
| Sun Mar 31 | $2.01 | $797.7M | 1 |